2 recruiting, 2 unknown. 4 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 4 | Recruiting 2, Unknown 2 |
Follow Thromboprophylaxis: new trials by email Literature Review of Thromboprophylaxis trials Research Report on Thromboprophylaxis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Apixaban to Prevent Venous Thromboembolism in Ambulatory Lung Cancer Patients Undergoing Systemic Anticancer Treatment Apixaban, Placebo - Thromboprophylaxis | Phase 3 | Recruiting | University of Birmingham | 1456 | 2026-04-28 | 2026-09-28 |
| RIVAroxaban Versus Low-molecular Weight Heparin in Patients With Lower Limb Trauma Requiring Brace or CASTing Rivaroxaban 10 MG, Low Heparin Molecular Weight - Venous Thromboembolism, Deep Vein Thrombosis | Phase 3 | Recruiting | University Hospital, Angers | 1424 | 2024-07-19 | 2026-06-25 |
| Venous Thromboembolism Prophylaxis After Gynecological Pelvic Cancer Surgery With Rivaroxaban vs Enoxaparin Rivaroxaban, Enoxaparin - Cancer, Rivaroxaban | Phase 3 | Unknown | André Luiz Malavasi Longo de Oliveira | 440 | 2020-10-22 | 2021-08-10 |
| Rivaroxaban for Thromboprophylaxis in High-risk Cancer Patients With Totally Implantable Access Ports Rivaroxaban - Rivaroxaban, Thromboprophylaxis | Phase 3 | Unknown | LiuZhou People's Hospital | 204 | 2020-03-08 | 2020-03-16 |
Neoplasms (2) · Venous Thromboembolism (2) · Venous Thrombosis (2) · Emergencies (1) · Pulmonary Embolism (1)
Cardiovascular Diseases (3) · Embolism and Thrombosis (3) · Vascular Diseases (3) · Thromboembolism (2) · Thrombosis (2) · Disease Attributes (1) · Embolism (1) · Lung Diseases (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1) · Respiratory Tract Diseases (1)
Rivaroxaban (3) · Dalteparin (1) · Enoxaparin (1) · apixaban (1)
André Luiz Malavasi Longo de Oliveira (1) · LiuZhou People's Hospital (1) · University Hospital, Angers (1) · University of Birmingham (1)
Brazil (1) · France (1) · United Kingdom (1)
Delphine Douillet, Doctor (1) · Eduardo Ramacciotti, MD, PhD (1) · Michael Newnham, MBChB, MSc, MRCP, PhD (1)
2023 (1)